FlashPath connects fragmented drug safety evidence to support scientists and drug developers. Its AI-powered platform brings together large-scale preclinical, regulatory, clinical, and post-market safety data to uncover insights, identify risks earlier, and support faster, more informed decisions. By making existing evidence easier to find, connect, and use, FlashPath helps teams de-risk clinical trials, accelerate drug development, and reduce unnecessary animal testing.
| Website | http://flashpathai.com |
| Employees | 5 (2 on RocketReach) |
| Founded | 2025 |
| Industry | Biotechnology Research |
Looking for a particular FlashPath employee's phone or email?
Sara Selitsky is the CEO of FlashPath.
2 people are employed at FlashPath.